- 5:00 PM
The MCW Department of Surgery’s Division of Surgical Oncology will be hosting the MCW and MD Anderson Cancer Center Endocrine Surgery Symposium on Friday, Feb. 23, at The Westin Milwaukee.
Surgical endocrine disorders are increasing in incidence, and the diagnosis and management are increasingly complex, often requiring multidisciplinary care by endocrinologists, radiologists, medical oncologists, and surgeons. This workshop will highlight the multidisciplinary approach and current national and international guidelines for these complex diseases. Invited speakers include well-known academic surgeons from both the Medical College of Wisconsin and the University of Texas MD Anderson Cancer Center.
The keynote speaker is R. Michael Tuttle, MD, an endocrinologist, professor of medicine and clinical director of the endocrinology service at Memorial Sloan Kettering Cancer Center in New York. He will be speaking on Risk Stratification in Differentiated Thyroid Cancer: Integrating the AJCC 8th Edition into Clinical Practice.
Dr. Tuttle designed and validated the first real-time risk assessment model for thyroid cancer management, in which individual risk estimates are modified over time as a function of response to initial therapy. In addition, his clinical studies have helped to define the role of recombinant human TSH as an adjuvant for radioactive iodine therapy in both low-risk and high-risk patients and in the setting of radioactive iodine avid distant metastases.
Please register for the event on the MCW & MD Anderson Cancer Center Endocrine Surgery Symposium Web page. If you do not have an Ethos account, create one in the upper right-hand corner first. *Note that the website does NOT work to its full capacity in Internet Explorer. Google Chrome and Mozilla Firefox are the preferred browsers.
This course is complimentary for fellows, residents and students – if you fit this description please email firstname.lastname@example.org your name to register.